Revenue jumps to $31,927M at Anheuser-Busch InBev (NYSE: BUD)
Anheuser-Busch InBev reported strong first-half 2026 results, with revenue of USD 31,927 million, up 11.5% year on year, on volumes up 0.3% to 280,412 thousand hectoliters. Normalized EBITDA rose 12.0% to USD 11,375 million and profit of the period increased 54.6% to USD 7,061 million.
Growth was driven by Middle Americas and South America, where revenue grew 18.1% and 16.2%, helped by premiumization, Beyond Beer and digital B2B platform BEES, whose gross merchandise value reached USD 29.6 billion. Reported net finance expense fell to USD 74 million from USD 1,678 million, mainly due to a USD 2,033 million positive mark-to-market on derivatives, lifting profit attributable to equity holders to USD 6,314 million and underlying EPS to USD 2.18. Cash flow from operating activities rose to USD 5,241 million and adjusted free cash flow to USD 3,881 million, while net debt stood at USD 64.2 billion against total liquidity of USD 18.1 billion as of 30 June 2026. The company also acquired 85% of BeatBox for USD 493 million and completed the USD 2.9 billion reacquisition of a 49.9% minority stake in its US metal container plants.
Positive
- Revenue up 11.5% to USD 31,927 million for the first half of 2026, with broad-based growth and especially strong contributions from Middle Americas and South America.
- Profit of the period rose 54.6% to USD 7,061 million, supported by higher profit from operations and a sharp reduction in reported net finance expense.
- Normalized EBITDA increased 12.0% to USD 11,375 million, while underlying profit attributable to equity holders grew to USD 4,314 million and Underlying EPS to USD 2.18.
- Adjusted free cash flow more than doubled to USD 3,881 million, reflecting stronger earnings and better working capital versus the prior-year period.
Negative
- None.
Key Figures
Key Terms
Normalized EBITDA financial
Hyperinflationary Price Cap financial
Adjusted free cash flow financial
net investment hedges financial
share-based payment programs financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How did Anheuser-Busch InBev (BUD) perform financially in the first half of 2026?
What drove AB InBev (BUD) revenue growth in the first half of 2026?
How did cash flow and net debt change for Anheuser-Busch InBev (BUD) in H1 2026?
What were Anheuser-Busch InBev (BUD) earnings per share in the first half of 2026?
What strategic investments did Anheuser-Busch InBev (BUD) make in H1 2026?
How did regional volumes and revenue trend for Anheuser-Busch InBev (BUD) in H1 2026?
What was the contribution of BEES and digital platforms to AB InBev (BUD) in H1 2026?
| Exhibit Number |
Description | |
99.1 |
Unaudited Interim Report for the six-month period ended 30 June 2026 | |
101 |
Inline Interactive Data File – The instance document does not appear separately because its XBRL tags are embedded within the inline XBRL document. | |
| ANHEUSER-BUSCH INBEV SA/NV (Registrant) | ||||||
| Dated: July 30, 2026 |
By: |
/s/ Jan Vandermeersch Name: Jan Vandermeersch Title: Global Legal Director Corporate | ||||

| • | global, regional and local economic weakness and uncertainty, including the risks of an economic downturn, recession, foreign exchange fluctuations, tariffs and/or inflationary pressures in one or more of our key markets, and the impact they may have on us, our customers and our suppliers and our assessment of that impact; |
| • | continued geopolitical instability (including as a result of the ongoing conflict between Russia and Ukraine, and conflicts and developments in the Middle East and Latin America), which may have a substantial impact on the economies of one or more of our key markets and may result in, among other things, disruptions to global supply chains, increases in commodity and energy prices with follow-on inflationary impacts, and economic and political sanctions; |
| • | financial risks, such as interest rate risk, foreign exchange rate risk (in particular as against the U.S. dollar, our reporting currency), commodity risk, asset price risk, equity market risk, counterparty risk, sovereign risk, liquidity risk, inflation or deflation, including inability to achieve our optimal net debt level; |
| • | changes in government policies and currency controls; |
| • | continued availability of financing and our ability to achieve our targeted coverage and debt levels and terms, including the risk of constraints on financing in the event of a credit rating downgrade; |
| • | the monetary and interest rate policies of central banks, in particular the European Central Bank, the Board of Governors of the U.S. Federal Reserve System, the Bank of England, Banco Central do Brasil, Banco Central de la República Argentina, the Central Bank of China, the South African Reserve Bank, Banco de la República in Colombia, the Bank of Mexico and other central banks; |
| • | changes in applicable laws, regulations and taxes in jurisdictions in which we operate, including the laws and regulations governing our operations and changes to tax benefit programs, as well as actions or decisions of courts and regulators; |
| • | limitations on our ability to contain costs and expenses or increase our prices to offset increased costs; |
| • | failure to meet our expectations with respect to expansion plans, growth, accretion to reported earnings, working capital improvements and investment income or cash flow projections; |
| • | our ability to continue to introduce competitive new products and services on a timely, cost-effective basis; |
| • | the effects of competition and consolidation in the markets in which we operate, which may be influenced by regulation, deregulation or enforcement policies; |
| • | changes in consumer preferences, spending and behavior; |
| • | changes in pricing environments; |
| • | volatility in the availability or prices of raw materials, commodities and energy; |
| • | damage to our reputation or the image and reputation of our brands; |
| • | difficulties in maintaining relationships with employees; |
| • | regional or general changes in asset valuations; |
| • | greater than expected costs (including taxes) and expenses; |
| • | climate change and other environmental concerns; |
| • | the risk of unexpected consequences resulting from acquisitions, joint ventures, strategic alliances, corporate reorganizations or divestiture plans, and our ability to successfully and cost-effectively implement these transactions and integrate the operations of businesses or other assets we have acquired; |
| • | the outcome of pending and future litigation, investigations and governmental proceedings; |
| • | natural and other disasters, including widespread health emergencies, cyberattacks and military conflict and political instability; |
| • | any inability to economically hedge certain risks; |
| • | inadequate impairment provisions and loss reserves; |
| • | technological disruptions, threats to cybersecurity and the risk of loss or misuse of personal data; |
| • | other statements included in this document that are not historical; and |
| • | our success in managing the risks involved in the foregoing. |
Six-month periodended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change |
||||||||||||
(USD Million, except volumes) |
(%) (1) |
|||||||||||||
Volumes (thousand hectoliters) |
280,412 | 279,615 | 0.3 | |||||||||||
Revenue |
31,927 | 28,632 | 11.5 | |||||||||||
Cost of sales |
(13,702) | (12,602) | (8.7) | |||||||||||
Gross profit |
18,225 | 16,029 | 13.7 | |||||||||||
Selling, General and Administrative expenses |
(9,917) | (8,812) | (12.5) | |||||||||||
Other operating income/(expenses) |
369 | 383 | (3.6 | ) | ||||||||||
Exceptional items |
14 | (94) | - | |||||||||||
Profit of the period |
7,061 | 4,568 | 54.6 | |||||||||||
Profit from operations |
8,691 | 7,506 | 15.8 | |||||||||||
Normalized EBITDA (2) |
11,375 | 10,156 | 12.0 | |||||||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
| (2) | Normalized EBITDA is a non-IFRS measure. For a discussion of how we use Normalized EBITDA and its limitations, and a table showing the calculation of our Normalized EBITDA, for the periods shown, see “—Normalized EBITDA” below. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change | ||||||||||
(thousand hectoliters) |
(%) (1) | |||||||||||
North America |
41,561 | 42,218 | (1.6) | |||||||||
Middle Americas |
75,979 | 73,903 | 2.8 | |||||||||
South America |
75,430 | 75,089 | 0.5 | |||||||||
EMEA |
45,169 | 44,924 | 0.5 | |||||||||
Asia Pacific |
42,134 | 43,365 | (2.8) | |||||||||
Global Export and Holding Companies |
139 | 116 | 19.7 | |||||||||
Total |
280,412 |
279,615 |
0.3 |
|||||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
| • | Effective 1 January 2026, Cervecería Bucanero S.A., a Cuban company in which we indirectly hold a 50% equity interest through our subsidiary Ambev, is accounted for as an associate using the equity method of accounting. |
| • | On 27 February 2026, we completed the acquisition of 85% of BeatBox Beverages, a ready-to-drink |
| • | A series of other acquisitions and disposals, including the acquisition and termination of certain distribution rights in 2025. See “Item 5. Operating and Financial Review—A. Key Factors Affecting Results of Operations—Acquisitions, Divestitures and Other Structural Changes—Acquisitions, Divestitures and Other Arrangements of our 2025 Annual Report for additional information. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change | ||||||||||
(USD million) |
(%) (1) | |||||||||||
North America |
7,424 | 7,208 | 3.0 | |||||||||
Middle Americas |
9,595 | 8,124 | 18.1 | |||||||||
South America |
6,402 | 5,507 | 16.2 | |||||||||
EMEA |
4,951 | 4,454 | 11.2 | |||||||||
Asia Pacific |
3,122 | 3,108 | 0.4 | |||||||||
Global Export and Holding Companies |
433 | 231 | 87.7 | |||||||||
Total |
31,927 |
28,632 |
11.5 |
|||||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
| • | The year-over-year price growth in Argentina beyond the Hyperinflationary Price Cap, and the 2025 and 2026 acquisitions and disposals had a negative impact of USD 106 million on our consolidated revenue for the six-month period ended 30 June 2026 compared to the six-month period ended 30 June 2025. |
| • | Our consolidated revenue for the six-month period ended 30 June 2026 also reflects a positive currency translation impact of USD 1,783 million mainly arising from currency translation effects in Middle Americas, South America and EMEA. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change | ||||||||||
(USD million) |
(%) (1) | |||||||||||
North America |
(2,932) | (2,947) | 0.5 | |||||||||
Middle Americas |
(3,259) | (2,866) | (13.7 | ) | ||||||||
South America |
(3,119) | (2,764) | (12.9 | ) | ||||||||
EMEA |
(2,473) | (2,280) | (8.5 | ) | ||||||||
Asia Pacific |
(1,441) | (1,456) | 1.1 | |||||||||
Global Export and Holding Companies |
(477) | (290) | (64.7 | ) | ||||||||
Total |
(13,702) |
(12,602) |
(8.7 |
) | ||||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
| • | The year-over-year price growth in Argentina beyond the Hyperinflationary Price Cap, and the 2025 and 2026 acquisitions and disposals had a positive impact of USD 72 million on our consolidated cost of sales for the six-month period ended 30 June 2026 compared to the six-month period ended 30 June 2025. |
| • | Our consolidated cost of sales for the six-month period ended 30 June 2026 also reflects a negative currency translation impact of USD 726 million mainly arising from currency translation effects in Middle Americas, EMEA and South America. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change | ||||||||||
(USD million) |
(%) (1) | |||||||||||
Selling, General and Administrative Expenses |
(9,917) | (8,812) | (12.5) | |||||||||
Other Operating Income/(Expenses) |
369 | 383 | (3.6) | |||||||||
Total Operating Expenses |
(9,548) |
(8,429) |
(13.3) |
|||||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change | ||||||||||
(USD million) |
(%) (1) | |||||||||||
North America |
(2,328) | (2,174) | (7.1) | |||||||||
Middle Americas |
(2,241) | (1,898) | (18.1) | |||||||||
South America |
(1,968) | (1,712) | (15.0) | |||||||||
EMEA |
(1,581) | (1,371) | (15.3) | |||||||||
Asia Pacific |
(1,015) | (941) | (7.9) | |||||||||
Global Export and Holding Companies |
(784) | (716) | (9.5) | |||||||||
Total |
(9,917) |
(8,812) |
(12.5) |
|||||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
| • | The year-over-year price growth in Argentina beyond the Hyperinflationary Price Cap, and the 2025 and 2026 acquisitions and disposals had a negative impact of USD 48 million on our consolidated selling, general and administrative expenses for the six-month period ended 30 June 2026 compared to the six-month period ended 30 June 2025. |
| • | Our consolidated selling, general and administrative expenses for the six-month period ended 30 June 2026 also reflect a negative currency translation impact of USD 486 million mainly arising from currency translation effects in Middle Americas, EMEA and South America. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change | ||||||||||
(USD million) |
(%) (1) | |||||||||||
North America |
18 | 23 | (22.4 | ) | ||||||||
Middle Americas |
(7 | ) | 14 | - | ||||||||
South America |
255 | 201 | 26.4 | |||||||||
EMEA |
73 | 101 | (27.0 | ) | ||||||||
Asia Pacific |
27 | 41 | (33.1 | ) | ||||||||
Global Export and Holding Companies |
3 | 2 | 27.5 | |||||||||
Total |
369 |
383 |
(3.6 |
) | ||||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
| ● | The year-over-year price growth in Argentina beyond the Hyperinflationary Price Cap, and the 2025 and 2026 acquisitions and disposals had a negative impact of USD 10 million on our net consolidated other operating income and expenses for the six-month period ended 30 June 2026 compared to the six-month period ended 30 June 2025. |
| ● | Our net consolidated other operating income and expenses for the six-month period ended 30 June 2026 also reflect a positive currency translation impact of USD 32 million mainly arising from currency translation effects in South America. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
(USD million) | ||||||||
Restructuring |
(33 | ) | (47 | ) | ||||
Business and asset disposal (including impairment losses) |
61 | (47 | ) | |||||
Acquisition-related costs (business combinations) |
(14 | ) | - | |||||
Total |
14 |
(94 |
) | |||||
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change | ||||||||||
(USD million) |
(%) (1) | |||||||||||
North America |
2,285 | 2,106 | 8.5 | |||||||||
Middle Americas |
4,076 | 3,360 | 21.3 | |||||||||
South America |
1,555 | 1,224 | 27.0 | |||||||||
EMEA |
972 | 906 | 7.2 | |||||||||
Asia Pacific |
691 | 739 | (6.5 | ) | ||||||||
Global Export and Holding Companies |
(887 | ) | (830 | ) | (7.0 | ) | ||||||
Total |
8,691 |
7,506 |
15.8 |
|||||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
| ● | The year-over-year price growth in Argentina beyond the Hyperinflationary Price Cap and the 2025 and 2026 acquisitions and disposals negatively impacted our consolidated profit from operations by USD 91 million for the six-month period ended 30 June 2026 compared to the six-month period ended 30 June 2025. |
| ● | Our consolidated profit from operations for the six-month period ended 30 June 2026 also reflects a positive currency translation impact of USD 597 million. |
| ● | Our profit from operations for the six-month period ended 30 June 2026 had a positive impact of USD 14 million due to certain exceptional items, as compared to a negative impact of USD 94 million for the six-month period ended 30 June 2025. See “Exceptional Items” above for a description of exceptional items that impacted our profit from operations for the six-month period ended 30 June 2026 and 2025. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change | ||||||||||
(USD million) |
(%) (1) | |||||||||||
Net interest expense |
(1,196 | ) | (1,284 | ) | 6.9 | |||||||
Accretion expense and interest on pensions |
(413 | ) | (351 | ) | (17.5 | ) | ||||||
Other financial results |
(498 | ) | (410 | ) | (21.6 | ) | ||||||
Net finance expense before exceptional finance results |
(2,107 |
) |
(2,046 |
) |
(3.0 |
) | ||||||
Mark-to-market |
2,033 | 339 | 500.1 | |||||||||
Gain/(loss) on bond redemption and other |
- | 29 | - | |||||||||
Exceptional net finance income/(expense) |
2,033 |
368 |
452.8 |
|||||||||
Net finance income/(expense) |
(74 |
) |
(1,678 |
) |
95.6 |
|||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
Share price at the start of the six-month period (in euro) |
54.90 | 48.25 | ||||||
Share price at the end of the six-month period (in euro) |
72.66 | 58.24 | ||||||
Number of derivative equity instruments at the end of the period (in millions) |
90.5 | 100.5 | ||||||
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
(USD million) | ||||||||
Profit attributable to non-controlling interests |
747 | 744 | ||||||
Profit attributable to equity holders of AB InBev |
6,314 | 3,824 | ||||||
Profit of the period |
7,061 |
4,568 |
||||||
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
(USD million) | ||||||||
Profit attributable to equity holders of AB InBev |
6,314 |
3,824 |
||||||
Exceptional items, before taxes |
(14 | ) | 94 | |||||
Exceptional net finance (income)/expense, before taxes |
(2,033 | ) | (368 | ) | ||||
Exceptional share of results of associates |
- | (9 | ) | |||||
Exceptional taxes |
18 | (17 | ) | |||||
Exceptional non-controlling interest |
(5 | ) | (5 | ) | ||||
Hyperinflation impacts |
35 | 37 | ||||||
Underlying profit, attributable to equity holders of AB InBev (1) |
4,314 |
3,556 |
||||||
| (1) | Underlying profit, attributable to equity holders of AB InBev is a non-IFRS measure. See “Item 5. Operating and Financial Review—E. Results of Operations—Year Ended 31 December 2025 Compared to the Year Ended 31 December 2024—Profit Attributable to Our Equity Holders” of our 2025 Annual Report for additional information on our definition and use of Underlying profit, attributable to equity holders of AB InBev. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
(USD per share) | ||||||||
Basic earnings per share |
3.20 |
1.92 |
||||||
Exceptional items, before taxes |
(0.01 | ) | 0.05 | |||||
Exceptional net finance (income)/expense, before taxes |
(1.03 | ) | (0.18 | ) | ||||
Exceptional share of results of associates |
- | (0.00 | ) | |||||
Exceptional taxes |
0.01 | (0.01 | ) | |||||
Exceptional non-controlling interest |
(0.00 | ) | (0.00 | ) | ||||
Hyperinflation impacts |
0.02 | 0.02 | ||||||
Underlying EPS (1) |
2.18 |
1.79 |
||||||
| (1) | Underlying EPS is a non-IFRS measure. See “Item 5. Operating and Financial Review—E. Results of Operations—Year Ended 31 December 2025 Compared to the Year Ended 31 December 2024—Profit Attributable to Our Equity Holders” of our 2025 Annual Report for additional information on our definition and use of Underlying EPS. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 |
Change | ||||||||||
(USD million) |
(%) (1) | |||||||||||
Profit attributable to equity holders of AB InBev |
6,314 | 3,824 | 65.1 | |||||||||
Profit attributable to non-controlling interests |
747 | 744 | 0.4 | |||||||||
Profit of the period |
7,061 |
4,568 |
54.6 |
|||||||||
Net finance expense |
74 | 1,678 | 95.6 | |||||||||
Income tax expense |
1,704 | 1,404 | (21.3 | ) | ||||||||
Share of result of associates |
(148 | ) | (135 | ) | 9.2 | |||||||
Exceptional share of results of associates |
- | (9 | ) | - | ||||||||
Profit from operations |
8,691 |
7,506 |
15.8 |
|||||||||
Exceptional items |
(14 | ) | 94 | - | ||||||||
Profit from operations, before exceptional items (2) |
8,677 |
7,601 |
14.2 |
|||||||||
Depreciation, amortization and impairment |
2,698 | 2,555 | (5.6 | ) | ||||||||
Normalized EBITDA (3) |
11,375 |
10,156 |
12.0 |
|||||||||
| (1) | The percentage change reflects the improvement (or worsening) of results for the period as a result of the change in each item. |
| (2) | Profit from operations, before exceptional items, is a non-IFRS measure. See “Item 5. Operating and Financial Review—E. Results of Operations—Year Ended 31 December 2025 Compared to the Year Ended 31 December 2024—Normalized EBITDA” of our 2025 Annual Report for additional information on our definition and use of Profit from operations, before exceptional items. |
| (3) | Normalized EBITDA is a non-IFRS measure. See “Item 5. Operating and Financial Review—E. Results of Operations—Year Ended 31 December 2025 Compared to the Year Ended 31 December 2024—Normalized EBITDA” of our 2025 Annual Report for additional information on our definition and use of Normalized EBITDA. |
Six-month period ended | ||||||||
30 June 2026 |
30 June 2025 | |||||||
U.S. dollar |
24.5 | % | 26.0 | % | ||||
Brazilian real |
15.4 | % | 14.1 | % | ||||
Mexican peso |
13.8 | % | 12.7 | % | ||||
Chinese yuan |
6.7 | % | 7.7 | % | ||||
Euro |
5.8 | % | 6.0 | % | ||||
Colombian peso |
5.9 | % | 5.0 | % | ||||
South African rand |
4.4 | % | 4.2 | % | ||||
Peruvian sol |
3.6 | % | 3.4 | % | ||||
Canadian dollar |
2.8 | % | 3.0 | % | ||||
Argentine peso (1) |
2.1 | % | 2.6 | % | ||||
Dominican peso |
2.0 | % | 2.1 | % | ||||
South Korean won |
1.8 | % | 2.0 | % | ||||
Pound sterling |
1.9 | % | 2.0 | % | ||||
Other |
9.3 | % | 9.0 | % | ||||
| (1) | Hyperinflation accounting was adopted starting from the September year-to-date |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
(USD million) | ||||||||
Cash flow from/(used in) operating activities |
5,241 | 2,704 | ||||||
Cash flow from/(used in) investing activities |
(1,807 | ) | (1,306 | ) | ||||
Cash flow from/(used in) financing activities |
(7,505 | ) | (5,837 | ) | ||||
Net increase/(decrease) in cash and cash equivalents |
(4,071 |
) |
(4,438 |
) | ||||
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
(USD million) | ||||||||
Profit of the period |
7,061 | 4,568 | ||||||
Interest, taxes and non-cash items included in profit |
4,459 | 5,736 | ||||||
Cash flow from operating activities before changes in working capital and provisions |
11,520 |
10,304 |
||||||
Change in working capital (1) |
(2,355 | ) | (3,655 | ) | ||||
Pension contributions and use of provisions |
(158 | ) | (278 | ) | ||||
Interest and taxes (paid)/received |
(3,866 | ) | (3,801 | ) | ||||
Dividends received |
101 | 135 | ||||||
Cash flow from/(used in) operating activities |
5,241 |
2,704 |
||||||
| (1) | Working capital includes inventories, trade and other receivables and trade and other payables, both current and non-current. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
(USD million) | ||||||||
Net capital expenditure |
(1,360 | ) | (1,350 | ) | ||||
Sale/(acquisition) and others related to subsidiaries, net of cash |
(757 | ) | (4 | ) | ||||
Proceeds from sale/(acquisition) of other assets |
310 | 47 | ||||||
Cash flow from/(used in) investing activities |
(1,807 |
) |
(1,306 |
) | ||||
| (1) | Net capital expenditure consists of acquisitions of plant, property and equipment and of intangible assets, minus proceeds from sale. |
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
(USD million) | ||||||||
Net (repayments of) / proceeds from borrowings |
246 | 68 | ||||||
Dividends paid |
(2,596) | (3,147) | ||||||
Share buyback |
(1,301) | (1,901) | ||||||
Payment of lease liabilities |
(364) | (354) | ||||||
Derivative financial instruments |
(319) | 114 | ||||||
Sale/(acquisition) of non-controlling interests |
(3,389) | (314) | ||||||
Other financing cash flows |
219 | (303) | ||||||
Cash flow from/(used in) financing activities |
(7,505) |
(5,837) |
||||||
Six-month period ended 30 June 2026 |
Six-month period ended 30 June 2025 | |||||||
(USD million) | ||||||||
Cash flow from operating activities |
5,241 | 2,704 | ||||||
Net capital expenditure (1) |
(1,360) | (1,350) | ||||||
Adjusted free cash flow (2) |
3,881 |
1,355 |
||||||
| (1) | Net capital expenditure consists of acquisitions of property, plant and equipment and of intangible assets, minus proceeds from sale; please see “—Cash Flow used in Investing Activities” above for further details regarding our net capital expenditures. |
| (2) | Adjusted free cash flow is a non-IFRS measure. See “Item 5. Operating and Financial Review—H. Liquidity and Capital Resources—Adjusted Free Cash Flow” of our 2025 Annual Report for additional information on our definition and use of adjusted free cash flow |

Statement of Profit or Loss Data |
Six-month period ended 30 June 2026 (1) |
Year ended 31 December 2025 (2) |
||||||
USD million |
||||||||
Revenue |
6,974 | 13,134 | ||||||
Gross profit |
3,781 | 6,879 | ||||||
Profit of the period |
120 | (1,023 | ) | |||||
Statement of Financial Position Data |
Six-month period ended 30 June 2026 |
Year ended 31 December 2025 |
||||||
USD million |
||||||||
Due from non-guarantor subsidiaries |
44,251 | 43,964 | ||||||
Other non-current assets |
61,662 | 61,248 | ||||||
Non-current assets |
105,913 |
105,212 |
||||||
Due from non-guarantor subsidiaries |
15,628 | 18,313 | ||||||
Other current assets |
5,582 | 8,642 | ||||||
Current assets |
21,210 |
26,954 |
||||||
Due to non-guarantor subsidiaries |
17,990 | 28,273 | ||||||
Other non-current liabilities |
74,322 | 77,397 | ||||||
Non-current liabilities |
92,312 |
105,670 |
||||||
Due to non-guarantor subsidiaries |
22,640 | 16,305 | ||||||
Other current liabilities |
11,275 | 11,094 | ||||||
Current liabilities |
33,915 |
27,400 |
||||||
| (1) | For the six-month period ended 30 June 2026, revenue, gross profit and profit of the period includes USD 130 million, USD (191) million and USD (2,373) million of intercompany transactions with non-guarantor subsidiaries and related parties, respectively. |
| (2) | For the year ended 31 December 2025, revenue, gross profit and profit of the period includes USD 228 million, USD (408) million and USD (978) million of intercompany transactions with non-guarantor subsidiaries and related parties, respectively. |
Condensed consolidated statement of profit or loss (unaudited) |
2 | |||
Condensed consolidated statement of comprehensive income (unaudited) |
3 | |||
Condensed consolidated statement of financial position (unaudited) |
4 | |||
Condensed consolidated statement of changes in equity (unaudited) |
5 | |||
Condensed consolidated statement of cash flows (unaudited) |
6 | |||
Notes to the consolidated financial statements |
7 |
For the six-month period ended 30 June |
||||||||||
Million US dollar, except earnings per share in US dollar |
Notes |
2026 |
2025 |
|||||||
Revenue |
||||||||||
Cost of sales |
( |
) | ( |
) | ||||||
Gross profit |
||||||||||
Distribution expenses |
( |
) | ( |
) | ||||||
Sales and marketing expenses |
( |
) | ( |
) | ||||||
Administrative expenses |
( |
) | ( |
) | ||||||
Other operating income/(expenses) |
||||||||||
Exceptional expenses above profit from operations |
7 | ( |
) | |||||||
Profit from operations |
||||||||||
Finance expense |
8 | ( |
) | ( |
) | |||||
Finance income |
8 | |||||||||
Net finance income/(expense) |
( |
) |
( |
) | ||||||
Share of results of associates |
13 | |||||||||
Exceptional share of results of associates |
7/13 | |||||||||
Profit before tax |
||||||||||
Income tax expense |
9 | ( |
) | ( |
) | |||||
Profit of the period |
||||||||||
Profit of the period attributable to: |
||||||||||
Equity holders of AB InBev |
||||||||||
Non-controlling interest |
||||||||||
Basic earnings per share |
16 | |||||||||
Diluted earnings per share |
16 | |||||||||
For the six-month period ended 30 June |
||||||||||
Million US dollar |
Notes |
2026 |
2025 |
|||||||
Profit of the period |
||||||||||
XXX |
||||||||||
Other comprehensive income/(loss): items that may be reclassified subsequently to profit or loss: |
||||||||||
Exchange differences on translation of foreign operations |
16 | |||||||||
Effective portion of changes in fair value of net investment hedges |
( |
) | ( |
) | ||||||
Cash flow hedges recognized in equity |
( |
) | ||||||||
Cash flow hedges reclassified from equity to profit or loss |
( |
) | ( |
) | ||||||
Other comprehensive income, net of tax |
||||||||||
Total comprehensive income |
||||||||||
Attributable to: |
||||||||||
Equity holders of AB InBev |
||||||||||
Non-controlling interest |
||||||||||
Million US dollar |
Notes |
30 June 2026 |
31 December 2025 |
|||||||
ASSETS |
||||||||||
Non-current assets |
||||||||||
Property, plant and equipment |
10 | |||||||||
Goodwill |
11 | |||||||||
Intangible assets |
12 | |||||||||
Investments in associates |
13 | |||||||||
Investment securities |
15 | |||||||||
Deferred tax assets |
||||||||||
Pensions and similar obligations |
||||||||||
Income tax receivables |
||||||||||
Derivatives |
19 | |||||||||
Trade and other receivables |
14 | |||||||||
Total non-current assets |
||||||||||
Current assets |
||||||||||
Investment securities |
15 | |||||||||
Inventories |
||||||||||
Income tax receivables |
||||||||||
Derivatives |
19 | |||||||||
Trade and other receivables |
14 | |||||||||
Cash and cash equivalents |
15 | |||||||||
Assets classified as held for sale |
||||||||||
Total current assets |
||||||||||
Total assets |
||||||||||
EQUITY AND LIABILITIES |
||||||||||
Equity |
||||||||||
Issued capital |
16 | |||||||||
Share premium |
||||||||||
Reserves |
||||||||||
Retained earnings |
||||||||||
Equity attributable to equity holders of AB InBev |
||||||||||
Non-controlling interests |
||||||||||
Total equity |
||||||||||
Non-current liabilities |
||||||||||
Interest-bearing loans and borrowings |
17 | |||||||||
Pensions and similar obligations |
||||||||||
Deferred tax liabilities |
||||||||||
Income tax payables |
||||||||||
Derivatives |
19 | |||||||||
Trade and other payables |
||||||||||
Provisions |
||||||||||
Total non-current liabilities |
||||||||||
Current liabilities |
||||||||||
Bank overdrafts |
15 | |||||||||
Interest-bearing loans and borrowings |
17 | |||||||||
Income tax payables |
||||||||||
Derivatives |
19 | |||||||||
Trade and other payables |
||||||||||
Provisions |
||||||||||
Total current liabilities |
||||||||||
Total equity and liabilities |
||||||||||
Attributable to equity holders of AB InBev |
||||||||||||||||||||||||||||||||||||||||
Issued |
Share |
Treasury |
Other comprehensive income |
Retained |
Non- controlling |
Total |
||||||||||||||||||||||||||||||||||
Million US dollar |
Notes |
Capital |
premium |
shares |
Reserves |
reserves |
earnings |
Total |
interest |
Equity |
||||||||||||||||||||||||||||||
As of 1 January 2025 |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
Profit of the period |
- | - | - | - | - | |||||||||||||||||||||||||||||||||||
Other comprehensive income/(loss) |
16 | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
Total comprehensive income/(loss) |
- |
- |
- |
- |
||||||||||||||||||||||||||||||||||||
Dividends |
- | - | - | - | - | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||||
Treasury shares |
- | - | ( |
) | - | - | ( |
) | ( |
) | - | ( |
) | |||||||||||||||||||||||||||
Share-based payments |
18 | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
Hyperinflation monetary adjustments |
- | - | - | - | - | |||||||||||||||||||||||||||||||||||
Scope and other changes |
- | - | - | - | - | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||||
As of 30 June 2025 |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
XXX |
||||||||||||||||||||||||||||||||||||||||
Attributable to equity holders of AB InBev |
||||||||||||||||||||||||||||||||||||||||
Issued |
Share |
Treasury |
Other comprehensive income |
Retained |
Non- controlling |
Total |
||||||||||||||||||||||||||||||||||
Million US dollar |
Notes |
Capital |
premium |
shares |
Reserves |
reserves |
earnings |
Total |
interest |
Equity |
||||||||||||||||||||||||||||||
As of 1 January 2026 |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
Profit of the period |
- | - | - | - | - | |||||||||||||||||||||||||||||||||||
Other comprehensive income/(loss) |
16 | - | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||||||
Total comprehensive income/(loss) |
- | - | - | - | ||||||||||||||||||||||||||||||||||||
Dividends |
- | - | - | - | - | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||||
Treasury shares |
- | - | - | - | ( |
) | - | |||||||||||||||||||||||||||||||||
Share-based payments |
18 | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
Hyperinflation monetary adjustments |
- | - | - | - | - | |||||||||||||||||||||||||||||||||||
Sale/(purchase) of non-controlling interests |
- | - | - | - | - | ( |
) | ( |
) | |||||||||||||||||||||||||||||||
Scope and other changes |
- | - | - | - | - | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||||
As of 30 June 2026 |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
For the six-month period ended 30 June |
||||||||||
Million US dollar |
Notes |
2026 |
2025 |
|||||||
OPERATING ACTIVITIES |
||||||||||
Profit of the period |
||||||||||
Depreciation, amortization and impairment |
||||||||||
Net finance (income)/expense |
8 | |||||||||
Equity-settled share-based payment expense |
18 | |||||||||
Income tax expense |
9 | |||||||||
Share of results of associates |
13 | ( |
) | ( |
) | |||||
Other non-cash items |
( |
) | ( |
) | ||||||
Cash flow from operating activities before changes in working capital and use of provisions |
||||||||||
Decrease/(increase) in trade and other receivables |
( |
) | ( |
) | ||||||
Decrease/(increase) in inventories |
( |
) | ( |
) | ||||||
Increase/(decrease) in trade and other payables |
( |
) | ( |
) | ||||||
Pension contributions and use of provisions |
( |
) | ( |
) | ||||||
Cash generated from operations |
||||||||||
Interest paid |
( |
) | ( |
) | ||||||
Interest received |
||||||||||
Dividends received |
||||||||||
Income tax paid |
( |
) | ( |
) | ||||||
Cash flow from/(used in) operating activities |
||||||||||
INVESTING ACTIVITIES |
||||||||||
Acquisition of property, plant and equipment and of intangible assets |
10 / 12 | ( |
) | ( |
) | |||||
Proceeds from sale of property, plant and equipment and of intangible assets |
||||||||||
Sale/(acquisition) and others related to subsidiaries, net of cash |
( |
) | ( |
) | ||||||
Proceeds from sale/(acquisition) of other assets |
||||||||||
Cash flow from/(used in) investing activities |
( |
) |
( |
) | ||||||
FINANCING ACTIVITIES |
||||||||||
Proceeds from borrowings |
17 | |||||||||
Repayments of borrowings |
17 | ( |
) | ( |
) | |||||
Dividends paid |
( |
) | ( |
) | ||||||
Share buyback |
( |
) | ( |
) | ||||||
Payment of lease liabilities |
( |
) | ( |
) | ||||||
Derivative financial instruments |
( |
) | ||||||||
Sale/(acquisition) of non-controlling interests |
( |
) | ( |
) | ||||||
Other financing cash flows |
( |
) | ||||||||
Cash flow from/(used in) financing activities |
( |
) |
( |
) | ||||||
Net increase/(decrease) in cash and cash equivalents |
( |
) |
( |
) | ||||||
Cash and cash equivalents less bank overdrafts at beginning of year |
||||||||||
Effect of exchange rate fluctuations |
||||||||||
Cash and cash equivalents less bank overdrafts at end of period |
15 | |||||||||
Note |
||||
Corporate information |
1 |
|||
Statement of compliance |
2 |
|||
Summary of significant accounting policies |
3 |
|||
Use of estimates and judgments |
4 |
|||
Segment reporting |
5 |
|||
Acquisitions and disposals of subsidiaries |
6 |
|||
Exceptional items |
7 |
|||
Finance expense and income |
8 |
|||
Income taxes |
9 |
|||
Property, plant and equipment |
10 |
|||
Goodwill |
11 |
|||
Intangible Assets |
12 |
|||
Investments in associates |
13 |
|||
Trade and other receivables |
14 |
|||
Cash and cash equivalents and investment securities |
15 |
|||
Changes in equity and earnings per share |
16 |
|||
Interest-bearing loans and borrowings |
17 |
|||
Share-based payments |
18 |
|||
Risks arising from financial instruments |
19 |
|||
Collateral and contractual commitments for the acquisition of property, plant and equipment, loans to customers and other |
20 |
|||
Contingencies |
21 |
|||
Related parties |
22 |
|||
Events after the reporting date |
23 |
|||
1. |
Corporate information |
2. |
Statement of compliance |
3. |
Summary of significant accounting policies |
(A) |
SUMMARY OF CHANGES IN ACCOUNTING POLICIES |
(B) |
FOREIGN CURRENCIES |
Closing rate |
Average rate |
|||||||||||||||
1 US dollar equals: |
30 June 2026 |
31 December 2025 |
30 June 2026 |
30 June 2025 |
||||||||||||
| Argentine peso |
- | - | ||||||||||||||
| Brazilian real |
||||||||||||||||
| Canadian dollar |
||||||||||||||||
| Chinese yuan |
||||||||||||||||
| Colombian peso |
||||||||||||||||
| Euro |
||||||||||||||||
| Mexican peso |
||||||||||||||||
| Peruvian sol |
||||||||||||||||
| Pound sterling |
||||||||||||||||
| South African rand |
||||||||||||||||
| South Korean won |
||||||||||||||||
(C) |
RECENTLY ISSUED IFRS |
| • | present specified categories, with the introduction of new operating, investing and financing categories, and defined subtotals in the statement of profit or loss; |
| • | provide disclosures on management-defined performance measures (MPMs) in the notes to the financial statements; and |
| • | strengthen the principles of aggregation and disaggregation across primary statements and notes. |
4. |
Use of estimates and judgments |
5. |
Segment reporting |
. |
North America |
Middle Americas |
South America |
EMEA |
Asia Pacific |
Global Export and Holding companies |
AB InBev Worldwide |
|||||||||||||||||||||||||||||||||||||||||||||||||
2026 |
2025 |
2026 |
2025 |
2026 |
2025 |
2026 |
2025 |
2026 |
2025 |
2026 |
2025 |
2026 |
2025 |
|||||||||||||||||||||||||||||||||||||||||||
Volume |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Profit from operations |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Net finance income/(expense) |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Share of results of associates |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exceptional share of results of associates |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax expense |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Profit |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment assets (non-current) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gross capex |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 |
Amended to conform to the 2026 presentation. |
6. |
Acquisitions and disposals of subsidiaries |
Million US dollar |
BeatBox |
|||
Non-current assets |
||||
Current assets |
||||
Current liabilities |
( |
|||
Non-controlling interest |
( |
|||
Assets and liabilities net of non-controlling interest |
||||
Goodwill on acquisition |
||||
Total consideration |
||||
Consideration to be paid |
( |
|||
Cash acquired |
( |
|||
Net cash outflow |
||||
7. |
Exceptional items |
For the six-month period ended 30 June |
||||||||
Million US dollar |
2026 |
2025 |
||||||
Restructuring |
( |
) | ( |
) | ||||
Business and asset disposal (incl. impairment losses) |
( |
) | ||||||
Acquisition-related costs (business combinations) |
( |
) | - | |||||
Net impact on profit from operations |
( |
) | ||||||
Exceptional net finance income/(expense) |
||||||||
Exceptional share of results of associates |
- | |||||||
Exceptional taxes |
( |
) | ||||||
Exceptional non-controlling interest |
||||||||
Net impact on profit |
||||||||
8. |
Finance expense and income |
For the six-month period ended 30 June |
||||||||
Million US dollar |
2026 |
2025 |
||||||
Interest expense |
( |
) | ( |
) | ||||
Interest income |
||||||||
Interest income on Brazilian tax credits |
||||||||
Net interest income/(expense) |
( |
) |
( |
) | ||||
Accretion expense |
( |
) | ( |
) | ||||
Interest on pensions |
( |
) | ( |
) | ||||
Accretion expense and interest on pensions |
( |
) |
( |
) | ||||
Net foreign exchange gains/(losses) |
( |
) | ( |
) | ||||
Net gains/(losses) on hedging instruments |
( |
) | ( |
) | ||||
Bank fees, taxes and other financial expense |
( |
) | ( |
) | ||||
Other financial income |
||||||||
Other financial results |
( |
) |
( |
) | ||||
Net finance income/(expense) excluding exceptional items |
( |
) |
( |
) | ||||
Exceptional finance income/(expense) |
||||||||
Net finance income/(expense) |
( |
) |
( |
) | ||||
| • | 2 033 m US dollar gain resulting from mark-to-market adjustments on derivative instruments related to the hedging of share-based payment programs and on derivative instruments entered into to hedge the shares issued in relation to the combinations with Grupo Modelo and SAB (30 June 2025: |
| • |
9. |
Income taxes |
For the six-month period ended 30 June |
||||||||
Million US dollar |
2026 |
2025 |
||||||
Current tax expense |
(1 743) |
(1 576) |
||||||
Deferred tax (expense)/income |
||||||||
Total income tax expense in the statement of profit or loss |
(1 704) |
(1 404) |
||||||
Million US dollar |
2026 |
2025 1 |
||||||
Profit/(loss) before tax |
||||||||
Deduct share of results of associates |
||||||||
Deduct exceptional share of results of associates |
||||||||
Profit before tax and before share of results of associates |
||||||||
Adjustments to the tax basis |
||||||||
Government incentives |
( |
( |
||||||
Non-deductible/(non-taxable) mark-to-market on derivatives |
( |
( |
||||||
Other expenses not deductible for tax purposes |
||||||||
Other non-taxable income |
( |
( |
||||||
Adjusted tax basis |
||||||||
Aggregate weighted nominal tax rate |
||||||||
Tax at aggregated nominal tax rate |
(1 871) |
( |
||||||
Adjustments on tax expense |
||||||||
Recognition/(de-recognition) of deferred tax assets on tax losses (carried forward) |
( |
( |
||||||
(Underprovided)/overprovided in prior years |
||||||||
Deductions from interest on equity |
||||||||
Deductions from goodwill and other tax deductions |
||||||||
Withholding taxes |
( |
( |
||||||
Other tax adjustments |
( |
( |
||||||
Total tax expense |
(1 704) |
( |
||||||
Effective tax rate |
||||||||
10. |
Property, plant and equipment |
Million US dollar |
30 June 2026 |
31 December 2025 |
||||||
Property, plant and equipment owned |
||||||||
Property, plant and equipment leased (right-of-use assets) |
||||||||
Total property, plant and equipment |
||||||||
30 June 2026 |
31 December 2025 |
|||||||||||||||||||
Million US dollar |
Land and buildings |
Plant and equipment, fixtures and fittings |
Under construction |
Total |
Total |
|||||||||||||||
Acquisition cost |
||||||||||||||||||||
Balance at end of previous year |
||||||||||||||||||||
Effect of movements in foreign exchange |
||||||||||||||||||||
Acquisitions |
||||||||||||||||||||
Disposals through sale and derecognition |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
Disposals through the sale of subsidiaries |
- | - | - | - | ( |
) | ||||||||||||||
Transfer (to)/from other asset categories and other movements¹ |
( |
) | ||||||||||||||||||
Balance at end of the period |
||||||||||||||||||||
Depreciation and impairment losses |
||||||||||||||||||||
Balance at end of previous year |
(5 743 |
) |
(29 876 |
) |
- |
( |
) |
( |
) | |||||||||||
Effect of movements in foreign exchange |
( |
) | ( |
) | - | (282 |
) | ( |
) | |||||||||||
Depreciation |
( |
) | ( |
) | - | (1 660 |
) | ( |
) | |||||||||||
Disposals through sale and derecognition |
- | |||||||||||||||||||
Disposals through the sale of subsidiaries |
- | - | - | - | ||||||||||||||||
Impairment losses |
- | ( |
) | - | ( |
) | ( |
) | ||||||||||||
Transfer to/(from) other asset categories and other movements 1 |
( |
) | - | ( |
) | ( |
) | |||||||||||||
Balance at end of the period |
(5 949 |
) |
(31 244 |
) |
- |
(37 193 |
) |
( |
) | |||||||||||
Carrying amount |
||||||||||||||||||||
at 31 December 2025 |
||||||||||||||||||||
at 30 June 2026 |
||||||||||||||||||||
30 June 2026 |
||||||||||||
Million US dollar |
Land and buildings |
Machinery, equipment and other |
Total |
|||||||||
Net carrying amount at 30 June |
||||||||||||
Depreciation for the six month period ended 30 June |
( |
) | ( |
) | ( |
) | ||||||
31 December 2025 |
||||||||||||
Million US dollar |
Land and buildings |
Machinery, equipment and other |
Total |
|||||||||
Net carrying amount at 31 December |
||||||||||||
Depreciation for the year ended 31 December |
( |
) | ( |
) | ( |
) | ||||||
11. |
Goodwi ll |
Million US dollar |
30 June 2026 |
31 December 2025 |
||||||
Acquisition cost |
||||||||
Balance at end of previous year |
||||||||
Effect of movements in foreign exchange |
||||||||
Acquisitions through business combinations |
||||||||
Transfers (to)/from other assets categories and other movements¹ |
( |
( |
||||||
Hyperinflation monetary adjustments |
||||||||
Balance at end of the period |
||||||||
Impairment losses |
||||||||
Balance at end of previous year |
( |
( |
||||||
Effect of movements in foreign exchange |
( |
( |
||||||
Transfers (to)/from other assets categories and other movements¹ |
||||||||
Balance at end of the period |
( |
( |
||||||
Carrying amount |
||||||||
Balance at end of the period |
||||||||
Million US dollar |
30 June 2026 |
31 December 2025 |
||||||
United States |
||||||||
Rest of North America |
||||||||
Mexico |
||||||||
Colombia |
||||||||
Rest of Middle Americas |
||||||||
Brazil |
||||||||
Rest of South America |
||||||||
Europe |
||||||||
South Africa |
||||||||
Rest of Africa |
||||||||
China |
||||||||
Rest of Asia Pacific |
||||||||
Total carrying amount of goodwill |
||||||||
12. |
Intangible assets |
30 June 2026 |
31 December 2025 |
|||||||||||||||||||||||
Million US dollar |
Brands |
Commercial intangibles |
Software |
Other |
Total |
Total |
||||||||||||||||||
Acquisition cost |
||||||||||||||||||||||||
Balance at end of previous year |
||||||||||||||||||||||||
Effect of movements in foreign exchange |
||||||||||||||||||||||||
Acquisitions through business combinations |
- | - | - | |||||||||||||||||||||
Acquisitions and expenditures |
||||||||||||||||||||||||
Disposals through sale and derecognition |
( |
( |
( |
( |
( |
( |
||||||||||||||||||
Transfer (to)/from other asset categories and other movements¹ |
( |
|||||||||||||||||||||||
Balance at end of period |
||||||||||||||||||||||||
Amortization and impairment losses |
||||||||||||||||||||||||
Balance at end of previous year |
( |
( |
( |
( |
( |
( |
||||||||||||||||||
Effect of movements in foreign exchange |
( |
( |
( |
( |
( |
|||||||||||||||||||
Amortization |
- | ( |
( |
( |
( |
( |
||||||||||||||||||
Impairment |
( |
( |
( |
( |
||||||||||||||||||||
Disposals through sale and derecognition |
||||||||||||||||||||||||
Transfer to/(from) other asset categories and other movements¹ |
- | ( |
( |
( |
( |
( |
||||||||||||||||||
Balance at end of period |
( |
( |
( |
( |
( |
( |
||||||||||||||||||
Carrying value |
||||||||||||||||||||||||
at 31 December 2025 |
||||||||||||||||||||||||
at 30 June 2026 |
||||||||||||||||||||||||
13. |
Investments in associates |
2026 |
2025 |
|||||||||||||||||||
Million US dollar |
Castel |
Anadolu Efes |
Castel |
Anadolu Efes |
||||||||||||||||
Balance as of 1 January |
||||||||||||||||||||
Effect of movements in foreign exchange |
( |
( |
( |
|||||||||||||||||
Dividends received |
( |
( |
( |
( |
||||||||||||||||
Share of results of associates |
( |
( |
||||||||||||||||||
Exceptional share of results of associates |
- | - | - | |||||||||||||||||
Balance as of 30 June |
||||||||||||||||||||
14. |
Trade and other receivables |
Million US dollar |
30 June 2026 |
31 December 2025 |
||||||
Cash deposits for guarantees |
||||||||
Loans to customers |
||||||||
Tax receivable, other than income tax |
||||||||
Brazilian tax credits and interest receivables |
||||||||
Trade and other receivables |
||||||||
Non-current trade and other receivables |
||||||||
Trade receivables and accrued income |
||||||||
Interest receivables |
||||||||
Tax receivable, other than income tax |
||||||||
Loans to customers |
||||||||
Prepaid expenses |
||||||||
Other receivables |
||||||||
Current trade and other receivables |
||||||||
Net carrying amount as of 30 June 2026 |
Of which: neither impaired nor past due on the reporting date |
Of which not impaired as of the reporting date and past due |
||||||||||||||||||||||||||
Less than 30 days |
Between 30 and 59 days |
Between 60 and 89 days |
More than 90 days |
|||||||||||||||||||||||||
Trade receivables and accrued income |
||||||||||||||||||||||||||||
Loans to customers |
- | - | ||||||||||||||||||||||||||
Interest receivables |
- | - | ||||||||||||||||||||||||||
Other receivables |
- | |||||||||||||||||||||||||||
- |
||||||||||||||||||||||||||||
Net carrying amount as of 31 December 2025 |
Of which: neither impaired nor past due on the reporting date |
Of which not impaired as of the reporting date and past due |
||||||||||||||||||||||||||
Less than 30 days |
Between 30 and 59 days |
Between 60 and 89 days |
More than 90 days |
|||||||||||||||||||||||||
Trade receivables and accrued income |
|
|
|
|
||||||||||||||||||||||||
Loans to customers |
- | |||||||||||||||||||||||||||
Interest receivables |
- | - | ||||||||||||||||||||||||||
Other receivables |
- | |||||||||||||||||||||||||||
15. |
Cash and cash equivalents and investment securities |
Million US dollar |
30 June 2026 |
31 December 2025 |
||||||
Short-term bank deposits |
||||||||
Cash and bank accounts |
||||||||
Cash and cash equivalents |
||||||||
Bank overdrafts |
( |
) | ( |
) | ||||
Cash and cash equivalents in the statement of cash flows |
||||||||
Million US dollar |
30 June 2026 |
31 December 2025 |
||||||
Investment in equity securities |
||||||||
Investment in debt securities |
||||||||
Non-current investments |
||||||||
Investment in debt securities |
||||||||
Current investments |
||||||||
16. |
Changes in equity and earnings per share |
Issued capital |
Million shares |
Million US dollar |
||||||
At the end of the previous year |
||||||||
Changes during the period |
||||||||
At the end of the current period |
||||||||
Of which: |
||||||||
Ordinary shares |
||||||||
Restricted shares |
||||||||
Treasury shares |
Result on the use of treasury shares |
|||||||||||
Treasury shares |
Million shares |
Million US dollar |
Million US dollar |
|||||||||
At the end of the previous year |
( |
) | ( |
) | ||||||||
Changes during the period |
( |
) | ( |
) | ||||||||
At the end of the current period |
( |
) |
( |
) | ||||||||
Post- |
||||||||||||||||
Translation |
Hedging |
employment |
Total OCI |
|||||||||||||
Million US dollar |
Reserves |
reserves |
benefits |
Reserves |
||||||||||||
As of 1 January 2026 |
( |
) |
( |
) |
( |
) | ||||||||||
Other comprehensive income/(loss) |
||||||||||||||||
Exchange differences on translation of foreign operations (gains/(losses)) |
- | - | ||||||||||||||
Cash flow hedges |
- | - | ||||||||||||||
Other comprehensive income/(loss) |
||||||||||||||||
As of 30 June 2026 |
( |
) |
( |
) |
( |
) | ||||||||||
Post- |
||||||||||||||||
Translation |
Hedging |
employment |
Total OCI |
|||||||||||||
Million US dollar |
Reserves |
reserves |
benefits |
Reserves |
||||||||||||
As of 1 January 2025 |
( |
) |
( |
) |
( |
) | ||||||||||
Other comprehensive income/(loss) |
||||||||||||||||
Exchange differences on translation of foreign operations (gains/(losses)) |
- | - | ||||||||||||||
Cash flow hedges |
- | ( |
) | - | ( |
) | ||||||||||
Other comprehensive income/(loss) |
( |
) |
||||||||||||||
As of 30 June 2025 |
( |
) |
( |
) |
( |
) | ||||||||||
Million shares |
2026 |
2025 |
||||||
Issued ordinary and restricted shares as of 1 January, net of treasury shares |
||||||||
Effect of stock lending |
||||||||
Effect of delivery of treasury shares and share buyback programs |
( |
) | ||||||
Weighted average number of ordinary and restricted shares as of 30 June |
||||||||
Million shares |
2026 |
2025 |
||||||
Weighted average number of ordinary and restricted shares as of 30 June |
||||||||
Effect of share options, PSUs and restricted stock units |
||||||||
Weighted average number of ordinary and restricted shares (diluted) as of 30 June |
||||||||
For the six-month period ended 30 June |
||||||||
Million US dollar |
2026 |
2025 |
||||||
Profit attributable to equity holders of AB InBev |
||||||||
Net impact of exceptional items on profit (refer to Note 7) |
( |
) | ( |
) | ||||
Profit, attributable to equity holders of AB InBev, before exceptional items |
||||||||
Hyperinflation impacts |
||||||||
Underlying profit |
||||||||
For the six-month period ended 30 June |
||||||||
Million US dollar |
2026 |
2025 |
||||||
Profit attributable to equity holders of AB InBev |
||||||||
Weighted average number of ordinary and restricted shares |
||||||||
Basic EPS |
||||||||
Profit attributable to equity holders of AB InBev |
||||||||
Weighted average number of ordinary and restricted shares (diluted) |
||||||||
Diluted EPS |
||||||||
Underlying profit |
||||||||
Weighted average number of ordinary and restricted shares |
||||||||
Underlying EPS |
||||||||
17. |
Interest-bearing loans and borrowings |
Million US dollar |
30 June 2026 |
31 December 2025 |
||||||
Unsecured bond issues |
||||||||
Lease liabilities |
||||||||
Unsecured other loans |
||||||||
Secured bank loans |
||||||||
Non-current interest-bearing loans and borrowings |
||||||||
Unsecured bond issues |
||||||||
Lease liabilities |
||||||||
Commercial papers |
||||||||
Unsecured bank loans |
||||||||
Unsecured other loans |
||||||||
Secured bank loans |
||||||||
Current interest-bearing loans and borrowings |
||||||||
Interest-bearing loans and borrowings |
||||||||
Million US dollar |
30 June 2026 |
31 December 2025 |
||||||
Non-current interest-bearing loans and borrowings |
||||||||
Current interest-bearing loans and borrowings |
||||||||
Interest-bearing loans and borrowings |
||||||||
Bank overdrafts |
||||||||
Cash and cash equivalents |
( |
) | ( |
) | ||||
Interest-bearing loans granted and other deposits (included within Trade and other receivables) |
( |
) | ( |
) | ||||
Debt securities (included within Investment securities) |
( |
) | ( |
) | ||||
Net debt |
||||||||
Million US dollar |
Long-term debt, net of current portion |
Short-term debt and current portion of long- term debt |
||||||
Balance as of 1 January 2026 |
||||||||
Proceeds from borrowings |
||||||||
Repayments of borrowings |
( |
) | ( |
) | ||||
Capitalization/(payment) of lease liabilities |
( |
) | ||||||
Amortized cost |
||||||||
Unrealized foreign exchange effects |
( |
) | ( |
) | ||||
Current portion of long-term debt |
( |
) | ||||||
(Gain)/Loss on bond redemption and other movements |
||||||||
Balance as of 30 June 2026 |
||||||||
Million US dollar |
Long-term debt, net of current portion |
Short-term debt and current portion of long- term debt |
||||||
Balance as of 1 January 2025 |
||||||||
Proceeds from borrowings |
||||||||
Repayments of borrowings |
( |
) | ( |
) | ||||
Capitalization/(payment) of lease liabilities |
( |
) | ||||||
Amortized cost |
||||||||
Unrealized foreign exchange effects |
||||||||
Current portion of long-term debt |
( |
) | ||||||
(Gain)/Loss on bond redemption and other movements |
||||||||
Balance as of 30 June 2025 |
||||||||
18. |
Share-based payments |
19. |
Risks arising from financial instruments |
30 June 2026 |
31 December 2025 |
|||||||||||||||||||||||||||||||
At fair |
At fair |
|||||||||||||||||||||||||||||||
value |
At fair |
value |
At fair |
|||||||||||||||||||||||||||||
At |
through |
value |
At |
through |
value |
|||||||||||||||||||||||||||
amortized |
profit or |
through |
amortized |
profit or |
through |
|||||||||||||||||||||||||||
Million US dollar |
cost |
loss |
OCI |
Total |
cost |
loss |
OCI |
Total |
||||||||||||||||||||||||
| Cash and cash equivalents |
- | - | - | - | ||||||||||||||||||||||||||||
| Trade and other receivables |
- | - | - | - | ||||||||||||||||||||||||||||
| Investment securities |
||||||||||||||||||||||||||||||||
| Foreign exchange derivatives |
- | - | ||||||||||||||||||||||||||||||
| Commodities |
- | - | - | - | ||||||||||||||||||||||||||||
| Cross currency interest rate swaps |
- | - | - | - | ||||||||||||||||||||||||||||
| Interest rate swaps |
- | - | - | - | ||||||||||||||||||||||||||||
| Financial assets |
||||||||||||||||||||||||||||||||
| Non-current |
- | |||||||||||||||||||||||||||||||
| Current |
||||||||||||||||||||||||||||||||
| Trade and other payables |
- | - | ||||||||||||||||||||||||||||||
| Non-current interest-bearing loans and borrowings |
- | - | ||||||||||||||||||||||||||||||
| Current interest-bearing loans and borrowings |
- | - | - | - | ||||||||||||||||||||||||||||
| Bank overdrafts |
- | - | - | - | ||||||||||||||||||||||||||||
| Equity swaps |
- | - | - | - | ||||||||||||||||||||||||||||
| Foreign exchange derivatives |
- | - | ||||||||||||||||||||||||||||||
| Commodities |
- | - | - | - | ||||||||||||||||||||||||||||
| Cross currency interest rate swaps |
- | - | - | - | ||||||||||||||||||||||||||||
| Interest rate swaps |
- | - | - | - | ||||||||||||||||||||||||||||
| Financial liabilities |
||||||||||||||||||||||||||||||||
| Non-current |
||||||||||||||||||||||||||||||||
| Current |
||||||||||||||||||||||||||||||||
B) |
INTEREST RATE RISK |
30 June 2026 |
Before hedging |
After hedging |
||||||||||||||
Interest-bearing financial liabilities |
Effective |
Effective |
||||||||||||||
Million US dollar |
interest rate |
Amount |
interest rate |
Amount |
||||||||||||
Floating rate |
||||||||||||||||
US dollar |
||||||||||||||||
Other |
||||||||||||||||
Fixed rate |
||||||||||||||||
US dollar |
||||||||||||||||
Euro |
||||||||||||||||
Chinese yuan |
||||||||||||||||
Canadian dollar |
||||||||||||||||
South Korean won |
||||||||||||||||
Mexican peso |
||||||||||||||||
Pound sterling |
||||||||||||||||
Other |
||||||||||||||||
31 December 2025 |
Before hedging |
After hedging |
||||||||||||||
Interest-bearing financial liabilities |
Effective |
Effective |
||||||||||||||
Million US dollar |
interest rate |
Amount |
interest rate |
Amount |
||||||||||||
Floating rate |
||||||||||||||||
US dollar |
||||||||||||||||
Other |
||||||||||||||||
Fixed rate |
||||||||||||||||
US dollar |
||||||||||||||||
Euro |
||||||||||||||||
Chinese yuan |
||||||||||||||||
Canadian dollar |
||||||||||||||||
South Korean won |
||||||||||||||||
Mexican peso |
||||||||||||||||
Pound sterling |
||||||||||||||||
Other |
||||||||||||||||
C) |
EQUITY PRICE RISK |
D) |
CREDIT RISK |
30 June 2026 |
31 December 2025 |
|||||||||||||||||||||||
Million US dollar |
Gross |
Impairment |
Net carrying amount |
Gross |
Impairment |
Net carrying amount |
||||||||||||||||||
Trade receivables |
( |
) | ( |
) | ||||||||||||||||||||
Other receivables |
( |
) | ( |
) | ||||||||||||||||||||
Trade and other receivables |
( |
) |
( |
) |
||||||||||||||||||||
30 June 2026 |
31 December 2025 |
|||||||
Balance at end of previous year |
( |
) |
( |
) | ||||
Impairment losses |
( |
) | ( |
) | ||||
Derecognition |
||||||||
Currency translation and other |
( |
) | ( |
) | ||||
Balance at end of period |
( |
) |
( |
) | ||||
E) |
LIQUIDITY RISK |
• |
Debt servicing; |
• |
Capital expenditures; |
• |
Investments in companies; |
• |
Increases in ownership of AB InBev’s subsidiaries or companies in which it holds equity investments; |
• |
Share buyback programs; and |
• |
Payments of dividends and interest on shareholders’ equity. |
30 June 2026 |
||||||||||||||||||||||||||||
Contractual |
Less |
More |
||||||||||||||||||||||||||
Carrying |
cash |
than |
than |
|||||||||||||||||||||||||
Million US dollar |
amount |
flows |
1 year |
1-2 years |
2-3 years |
3-5 years |
5 years |
|||||||||||||||||||||
Non-derivative financial liabilities |
||||||||||||||||||||||||||||
Unsecured bond issues |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Trade and other payables |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Lease liabilities |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Secured bank loans |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Unsecured bank loans |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
Unsecured other loans |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Commercial papers |
( |
) | ( |
) | ( |
) | - | - | - | - | ||||||||||||||||||
Bank overdrafts |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||||||||
Derivative financial liabilities |
||||||||||||||||||||||||||||
Equity derivatives |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
Foreign exchange derivatives |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Cross currency interest rate swaps |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Interest rate swaps |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
Commodity derivatives |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||||||||||
Of which: related to cash flow hedges |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
31 December 2025 |
||||||||||||||||||||||||||||
Contractual |
Less |
More |
||||||||||||||||||||||||||
Carrying |
cash |
than |
than |
|||||||||||||||||||||||||
Million US dollar |
amount |
flows |
1 year |
1-2 years |
2-3 years |
3-5 years |
5 years |
|||||||||||||||||||||
Non-derivative financial liabilities |
||||||||||||||||||||||||||||
Unsecured bond issues |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Trade and other payables |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Lease liabilities |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Secured bank loans |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Unsecured bank loans |
( |
) | ( |
) | ( |
) | - | - | - | - | ||||||||||||||||||
Unsecured other loans |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Bank overdrafts |
( |
) | ( |
) | ( |
) | - | - | - | - | ||||||||||||||||||
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||||||||
Derivative financial liabilities |
||||||||||||||||||||||||||||
Equity derivatives |
( |
) | ( |
) | ( |
) | - | - | - | - | ||||||||||||||||||
Foreign exchange derivatives |
( |
) | ( |
) | ( |
) | ( |
) | - | ( |
) | - | ||||||||||||||||
Cross currency interest rate swaps |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Interest rate swaps |
( |
) | ( |
) | ( |
) | - | - | - | |||||||||||||||||||
Commodity derivatives |
( |
) | ( |
) | ( |
) | - | - | - | - | ||||||||||||||||||
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||||||||
Of which: related to cash flow hedges |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
F) |
FAIR VAL UE |
Interest-bearing financial liabilities |
30 June 2026 |
31 December 2025 |
||||||||||||||
Million US dollar |
Carrying amount |
Fair value |
Carrying amount |
Fair value |
||||||||||||
Fixed rate |
||||||||||||||||
US dollar |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Euro |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Pound sterling |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Canadian dollar |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Other |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
( |
) |
( |
) |
( |
) |
( |
) | |||||||||
Fair value hierarchy as of 30 June 2026 Million US dollar |
Quoted (unadjusted) prices - level 1 |
Observable market inputs - level 2 |
Unobservable market inputs - level 3 |
|||||||||
Financial Assets |
||||||||||||
Derivatives at fair value through profit and loss |
- | - | ||||||||||
Derivatives in a cash flow hedge relationship |
- | |||||||||||
Derivatives in a net investment hedge relationship |
- | - | ||||||||||
- |
||||||||||||
Financial Liabilities |
||||||||||||
Deferred consideration on acquisitions at fair value |
- | - | ||||||||||
Derivatives at fair value through profit and loss |
- | - | ||||||||||
Derivatives in a cash flow hedge relationship |
- | |||||||||||
Derivatives in a fair value hedge relationship |
- | - | ||||||||||
Derivatives in a net investment hedge relationship |
- | - | ||||||||||
Fair value hierarchy as of 31 December 2025 Million US dollar |
Quoted (unadjusted) prices - level 1 |
Observable market inputs - level 2 |
Unobservable market inputs - level 3 |
|||||||||
Financial Assets |
||||||||||||
Derivatives at fair value through profit and loss |
- | - | ||||||||||
Derivatives in a cash flow hedge relationship |
- | |||||||||||
Derivatives in a net investment hedge relationship |
- | - | ||||||||||
- |
||||||||||||
Financial Liabilities |
||||||||||||
Deferred consideration on acquisitions at fair value |
- | - | ||||||||||
Derivatives at fair value through profit and loss |
- | - | ||||||||||
Derivatives in a cash flow hedge relationship |
- | |||||||||||
Derivatives in a fair value hedge relationship |
- | - | ||||||||||
Derivatives in a net investment hedge relationship |
- | - | ||||||||||
20. |
Collateral and contractual commitments for the acquisition of property, plant and equipment, loans to customers and other |
21. |
Contingencies |
Million US dollar |
30 June 2026 |
31 December 2025 |
||||||
| Income tax and social contribution |
||||||||
| Value-added and excise taxes |
||||||||
| Other taxes |
||||||||
22. |
Related parties |
23. |
Events after the reporting date |